Latham & Watkins LLP represented Zogenix in the offering. Zogenix, Inc., a global biopharmaceutical company, has announced the pricing of its offering of US$200 million aggregate…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now